Pharmacokinetics and safety of co-administered paritaprevir plus ritonavir, ombitasvir, and dasabuvir in hepatic impairment

Authors

Keywords

Paritaprevir, Ombitasvir, Dasabuvir, Ritonavir, Pharmacokinetics, Chronic hepatitis C, Hepatic impairment, Direct-acting antiviral agents

Journal

Volume 63, Issue 4, Pages 805-812

Publisher

Elsevier BV

Online

2015-06-13

DOI

10.1016/j.jhep.2015.05.029

Contact the author

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started